Wound-Healing in Mice Triggers Growth of Dormant Tumors

Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.

Apr 12, 2018
Jim Daley


The wound-healing process after cancer surgery can cause dormant tumors to begin growing in injured mice, researchers reported yesterday (April 11) in Science Translational Medicine. The finding may explain why metastatic recurrence is common in breast cancer patients following surgery.

“It’s not the actual surgery, but instead, it’s the post-surgical wound response,” coauthor Robert Weinberg, a biologist at MIT, tells USA Today. “It is provoking already disseminated cells to begin to grow into clinically detectable metastases.”

Weinberg and his colleagues observed that T cells prevented tumors from proliferating by keeping them in a dormant state. They hypothesized that when the immune system is preoccupied with wound recovery, its ability to keep cancer cells in check is compromised. To test whether cancer surgery could cause the cancer cells to awaken, they first injected mice with breast cancer cells, allowed tumors to grow, and then surgically removed previously implanted sterile sponges from the mice. The sponges were used to model the resection of a mass, while the tumors were left intact to avoid disturbing them and to maintain consistency across the animals.

They found that in mice who were operated on, 60 percent of the tumors continued to grow. In control mice that did not undergo surgery, only 10 percent of tumors persisted.

A previously published study found that anti-inflammatory analgesics reduced the rates of metastatic relapse in breast cancer patients. Based on this, the researchers treated mice with meloxicam, a nonsteroidal anti-inflammatory drug (NSAID), to determine whether it would impact their tumor growth. Cancers were much smaller in wounded mice who were treated with meloxicam than mice who were given saline controls. The treatment did not affect tumor growth in non-wounded mice.   

“I do not know if this mimics the potential effect of a lumpectomy or mastectomy, but the inflammatory response to an implanted foreign body would be expected to be quite robust,” Deanna Attai, a breast surgeon at the University of California, Los Angeles, tells STAT. It may be the inflammation causing the dormant cancer cells to activate, rather than anything associated with surgery, she adds.

See “Tumor Traps


November 2018

Intelligent Science

Wrapping our heads around human smarts


Sponsored Product Updates

Complete Pathology Solutions: Make Every Minute Count

Complete Pathology Solutions: Make Every Minute Count

From sample collection and handling, to fixation and processing, tissue staining, and covering all your IHC and water purification needs—you can have confidence in the quality of your results with MilliporeSigma's one-stop pathology solution.

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.